Monthly Archives: August 2023

Screen Australia and ABC announce Fresh Blood 3 teams – Media centre

09 08 2023 – Media release Fresh Blood 3 teams in Sydney for the workshop on 8 August 2023 The ABC and Screen Australia have announced the 10 successful teams for the 2023 Fresh Blood initiative. Fresh Blood has been the launchpad for the careers of some of Australia’s best comedy writers, directors, and performers. […]

First cases of West Nile virus reported in San Bernardino County this year

Cases of West Nile virus were confirmed in San Bernardino County on Tuesday as authorities are warning the public to be cautious. The infections mark the first locally acquired human cases of West Nile virus in the county this year and have been confirmed in Rialto and San Bernardino, according to the Department of Public […]

Weight-loss drug Wegovy could reduce risk of heart attack or stroke

Danish pharmaceutical company Novo Nordisk says the medicine could reduce the risk of cardiovascular disease. But they’re also facing a lawsuit about severe side effects of its main ingredient. The weight loss drug Wegovy could reduce the risk of cardiovascular disease based on the results of a trial, the company behind the drug said in […]

New COVID-19 Variant EG.5. (Eris) May Be Driving Uptick in Infections

New COVID-19 variants keep coming at us, fast and furious. Just two weeks ago, the XBB.1.5 variant accounted for the largest percentage of reported coronavirus cases in the United States (15.4 percent), according to the Centers for Disease Control and Prevention (CDC). But the latest numbers, published this week, show that the fast-spreading EG.5 variant […]

MacroGenics Provides Update on Corporate Progress and Second Quarter 2023 Financial Results

Advancing enrollment of TAMARACK Phase 2 study in metastatic castration-resistant prostate cancer (mCRPC) under revised protocol Initiating lorigerlimab Phase 2 study in mCRPC patients Achieved $50 million milestone related to Sanofi’s announcement of positive top-line data from TZIELD® (teplizumab-mzwv) type 1 diabetes study Conference call scheduled for today at 4:30 p.m. ET  ROCKVILLE, Md., Aug. 09, […]

Use of ART Did Not Harm Moms’ Long-Term Cardiovascular Health

Women who conceived with assisted reproductive technology (ART) did not have worse long-term cardiovascular outcomes, according to a large Nordic registry-based study. Between those who gave birth with and without ART, risk of cardiovascular disease (CVD) was similar over a median 11 years of follow-up (adjusted HR 0.97, 95% CI 0.91-1.02), reported researchers led by […]

Around the nation: Wegovy reduces the risk of serious cardiovascular events by 20%

Expert Insight It takes a Village(MD): 2 key reasons Walgreens is a player to watch With a $6.2 billion investment in VillageMD, Walgreens is transforming the way healthcare is delivered to rural America. Here’s how the retail giant is using their acquisition strategy to expand access to primary, specialty, and urgent care.

Myocardial bioenergetic profiling in patients with stable ischemic heart disease

Patients with chronic ischemic heart disease — an important cause of heart failure — show altered myocardial bioenergetics with metabolomic and transcriptomic changes that seem to occur at a global, rather than regional, level in human hearts. This is a preview of subscription content, access via your institution Access options Access through your institution Change […]

Insights into different populations’ immune responses to SARS-CoV-2 infection

RESEARCH BRIEFINGS 09 August 2023 Analysis of immune responses to SARS-CoV-2 at single-cell resolution reveals marked differences across human populations that are caused by previous infections and genetic variation. Natural selection and past reproduction with Neanderthals contributed to these differing immune responses and disparities in COVID-19 risk.